OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could Fine-Tune radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test (NavDx) can help doctors decide the right amount of radiation for people with HPV-related throat cancer. The goal is to give enough treatment to control the cancer while reducing side effects. About 455 adults with certain stages of throat ca…
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Throat cancer HPV study looks at hidden infection risks in women
Knowledge-focused Recruiting nowThis study looks at how often women who have throat cancer caused by HPV, or who have a partner with this cancer, get HPV infections in their genital or anal areas. Researchers will compare these rates to similar women without throat cancer. The goal is to better understand the r…
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 11:31 UTC